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Objectives. To create a preliminary taxonomy and related toolkit of health-related habits (HrH) following a person-centered
approachwithafocusonprimarycare.Methods.From2003–2009,aworkinggroup(n = 6physicians)deﬁnedtheknowledgebase,
createdaframingdocument,andselectedevaluationtoolsusinganiterativeprocess.Multidisciplinaryfocusgroups(n = 29health
professionals) revised the document and evaluation protocol and participated in a feasibility study and review of the model based
on a demonstration study with 11 adult volunteers in Antequera, Spain. Results. The preliminary taxonomy contains 6 domains
of HrH and 1 domain of additional health descriptors, 3 subdomains, 43 dimensions, and 141 subdimensions. The evaluation
tool was completed by the 11 volunteers. The eVITAL toolkit contains history and examination items for 4 levels of engagement:
self-assessment, basic primary care, extended primary care, and specialty care. There was positive feedback from the volunteers
and experts, but concern about the length of the evaluation. Conclusions. We present the ﬁrst taxonomy of HrH, which may aid the
development of the new models of care such as the personal contextual factors of the International Classiﬁcation of Functioning
(ICF) and the positive and negative components of the multilevel person-centered integrative diagnosis model.
1.Introduction
Noncommunicable diseases cause 6 out of 10 deaths, and
cardiovasculardiseasealonecauses31.5%ofdeathsinfemale
and 26.8% in males [1]. Many of the leading causes of death
have evidence-based modiﬁable risk factors [2–4], but this
does not always translate to healthy behavior by individuals.
Several studies have shown that risk of mortality or disease
decreases stepwise based on the number of healthy habits
practiced by an individual [5, 6]. In spite of the fact that
major chronic diseases are caused by multiple risks, which
when combined are associated with health outcomes, the
science of multiple health behavior change and assessment is
at an early stage, and factors that facilitate or impede success
in investigative or clinical intervention in multiple behavior
change are unknown [7].
The developing ﬁeld of longevity medicine takes a
holistic view of health that calls for integrative evaluation of
health-related habits (HrHs), both those that increase and
decrease risk of disease and those related to general health
and well-being, considering the endpoint of years lived
without disability and taking into account a person-centered
approach [8]. Taxonomies are particularly important in
developing ﬁelds of study in that they standardize terminol-
ogyandallowforcommonunderstandingofresearchresults;
recentlyproposedexamplesincludetheﬁeldsofadversedrug
reactions [9] and patient-initiated medical errors [10]. In
the current study, we present a preliminary taxonomy for2 The Scientiﬁc World Journal
Table 1: Metabolic classiﬁcation based on body mass index and
physical activity (eVITAL).
Body mass index (BMI) Physical activity
(a) Underweight (BMI <18.5) (i) Sedentary
(b) Normal weight (BMI 18.5–25) (ii) Daily activity, no
purposeful exercise
(c) Overweight (BMI 25–30) (iii) Regular exercise
(d) Obese (BMI >30) (iv) Very active
HrH, as well as the Spanish version of the eVITAL toolkit for
clinical evaluation of the lifestyle and related determinants of
longevity of an individual.
2. Methods
Methods and ethics are described in detail elsewhere [11].
In short, the taxonomy and the related eVITAL toolkit were
created using a nominal group technique involving a core
group of 6 physicians with expertise in various aspects of
longevity medicine and 29 health professionals, including
physicians, nurses, and psychologists, in a series of four
multidisciplinary focus groups. The model used in the
creationofthetaxonomywasadaptedfromtheInternational
Classiﬁcation of Functioning, Disability and Health (ICF)
[12]andotherdocumentsbytheWorldHealthOrganization
(WHO) [13–15], as well as the multilevel person-centered
integrative diagnosis model [16], and the transtheoretical
model of stages of change [17]a n dr e l a t e dm o d e lo f
multibehavior change [18]. According to the ICF a “domain”
is “a practical and meaningful set of related physiological
functions, anatomical structures, actions, tasks, or areas of
life” [12]. “Dimensions” are the identiﬁable components of
every domain. In some cases mutually exclusive domains
could not be categorized and subdomains had to be deﬁned
(see below).
Entities were organized hierarchically into constructs,
domains, subdomains, dimensions, subdimensions, and in-
dividual items, and codes were assigned using a hierarchical
tree. In this conceptual model, health behaviors are part of
HrH, complex behavioral patterns which are closely related
to other determinants of health as well as to speciﬁc health
conditions. HrH are in turn part of the health lifestyle, which
is a key component of the “personal factors” deﬁned in the
ICF. These personal factors “are the particular background
of an individual’s life and living,” and these factors comprise,
among others, “ﬁtness, lifestyle, habits...overall behaviour
pattern and character style, individual psychological assets
and other characteristics, all or any of which may play a role
in disability at any level” [12].
A demonstration study was performed with 11 adult
volunteers who completed the evaluation package followed
by an open-ended feedback questionnaire. The assessment
package was then revised and computerized, the experts
involved in the focus groups evaluated the feasibility of the
online toolkit using the criteria of applicability, acceptability,
and practicality [54], and responses were used to further
reﬁne eVITAL.
3. Results
3.1. Domains and Dimensions. The working group and
experts revised 7 proposed domains (physical activity,
diet, cognition, sleep, stress, psychosocial vitality, and risk
behaviors) into the ﬁnal 6 HrH domains by combining
vitality and stress into a single domain combining physical
activity and diet into one domain, and dividing “other risk
behaviors” into the two domains of substance use and other
risk habits (Table 2); the domains of cognition and sleep
were unchanged. After discussion regarding the placement
of sexuality within the hierarchy, it was decided that, while
important for quality of life, sexuality does not meet all
of the criteria for domains in terms of contributing to
years lived without disability; it was therefore included as a
subdimension within the vitality and stress domain. Despite
the initial intention to only include evaluation of HrH, the
working group decided that the clinical utility of the toolkit
would be increased by including an assessment of other
determinants and conditions of health speciﬁcally related to
each basic HrH.
The panel suggested creating an overarching “health
lifestyle proﬁle,” with 6 subproﬁles related to the 6 basic
HrHs. A seventh domain, “Health descriptors,” includes
generic descriptors of health related to longevity, such as
social and medical determinants of health and current status
of health.
The complete taxonomy developed through this process
is shown in Table 3. The preliminary taxonomy includes
6 domains or classes (with diet/exercise further divided
into three subdomains: generic, diet, and exercise), 43
dimensions or subclasses, and 141 subdimensions. Once
the preliminary taxonomy was deﬁned, codes were assigned
to each entity and subentity following a hierarchical tree
structure. Letters code the main branches or domains:
cognition (c), vitality/stress (v), sleep (s), diet/exercise (de),
substance use (s), and other risk habits (r). Each letter is
followed by a number for the branches, or dimensions,
except for the Prochaska stage of change which is coded
within each domain by the letter “s” (see Table 3). The
complete evaluation schema is shown in Table 4; the toolkit
is available online at http://www.longevidad.org/.
Regarding cognition, the working group and expert pan-
els included evaluation tools related to intellectual reserve
or to a higher vulnerability to problems with memory or
other higher cognitive functions. Tools were selected for
the vitality and stress domain to evaluate psychological and
social characteristics that are associated with longevity or an
improved response to stress and illness. The group decided
to include a biologic dimension to this domain due to the
evidence linking stress to these components of allostatic
load [55]. It was decided that, while diet and exercise have
traditionally been considered separate domains, there is
suﬃcient overlap in evaluation, clinical consequences, and
intervention strategies that they should be combined. For
example, both diet and exercise aﬀect body mass index,
which can be combined with activity level to form 16
metabolic types (Table 1). For substance use, the group
considered 3 categories: substances that are always harmfulThe Scientiﬁc World Journal 3
Table 2: eVITAL lifestyle proﬁle related to health habits and the Prochaska stage of change in 11 volunteers.
Subject Cognition Vitality
and stress Sleep
Diet and exercise Substance
use
Other risk
habits Main health conditions (ICD-10)
Ex. Diet
1 ↑↑↓ ↓ M ↓P ↑↑ Insomnia, sleep apnea, overweight, high
cholesterol
2 ↑↑ —— C — M— M ↑ High cholesterol
3 ↑↓↓ ↓ P ↓PR ↑↑ Sleep apnea (mild), osteoporosis,
Sj¨ ogren’s syndrome
4 ↑↑↓ ↓ C ↓P ↓C ↓C Sleep apnea, overweight/sedentariness,
nicotine abuse, hypertension
5 ↑↑↓ —M ↓P ↓P ↑ Sleep apnea (mild), overweight
6 ↑↑↓ —M ↓M ↑↑ Sleep apnea (mild)
7 ↑↑↑ —M —M ↑↑ Anxiety
8 ↑↓↓ ↓ P ↓P ↑↑
Anxiety, insomnia,
overweight/sedentariness, high
cholesterol
9 ↑↑↓ ↓ R ↓R ↓P ↑ Sleep apnea (mild), sedentariness,
nicotine abuse, diabetes (type 2)
10 — ↑↓ —C —P ↑ —P Sleep apnea, prostate cancer
11 — ↑↑ —C ↓C ↓C ↓A Anxiety, overweight, nicotine abuse
eVITAL Health stage: good (↑), acceptable (—), needs improvement (↓), the Prochaska stage of change (in domains where this is highly relevant and the
global impression rating is acceptable or needs improvement): precontemplation (P), contemplation (C), preparation (PP), action (A), maintenance( M ) ,
termination (T), relapse (R). Subjects were 11 adult volunteers in Antequera, Spain, who reported themselves to be healthy. Assessment occurred in 2008.
such as nicotine and cocaine, those that can be health
promoting in moderation such as wine and caﬀeine, and
medication abuse, due to the potential harm done by misuse
of all types of substances. For each substance, the following
factors were considered: type/form, timing of use, amount
consumed, degree of abuse, and related psychosocial and
medical problems. The expert group separated substance
use habits and non-substance-related risk habits due to
diﬀerences in assessment, intervention, and evidence related
to longevity. This ﬁnal domain, “other risk habits,” is divided
into treatment nonadherence and other risky behaviors;
patient error related to treatment nonadherence is not
further delineated within this preliminary taxonomy but has
recently been described in detail [10].
3.2. Assessment Package. The evaluation is divided into
four levels of increasing complexity, starting with basic
self-assessment tools (Level 0) and progressing through
assessments that can be completed in a basic primary care
visit by a nonphysician provider (Level 1), in an extended
primarycarevisitrequiringphysicianexpertise(Level2),and
in specialty care (Level 3). Within each level the evaluation is
divided into two parts: anamnesis (items related to history)
and medical exam.
The anamnesis includes 4 templates, 44 inventories, 22
rating scales, 5 sections (sleep, appetite, fatigue, obsessions,
and hypochondriasis) of the semi structured interview
“Standardized Polyvalent Psychiatric Interview” (SPPI) (also
known by its Spanish acronym EPEP) [40], and 6 sub-
classiﬁcation systems (Table 4). We selected assessment
instruments that were feasible at each assessment level
according to level of complexity and need for trained
expertise; when available, we prioritized items that had been
standardized in Spain. When instruments were not available,
the group designed inventories that should be standardized
and validated at a later stage. In all, the full assessment
package comprises 1078 items.
The medical exam includes physical exam ﬁndings
(signs and measures) and laboratory tests. A series of stan-
dard indexes have been incorporated. The group designed
adjusted indexes of cognitive reserve and body mass index
that require future validation (Table 3).
The assessment package uses several possible methods
of scoring the evaluation. In the simplest, after evaluating
each domain, the rater gives a global impression score of
the patient’s proﬁle for that domain in a 3-point Likert scale
(good, acceptable, or needs improvement). These scores can
be plotted for each of the domains in a health lifestyle proﬁle
and compared to the individual’s stage of change for each
domain to formulate a plan of care. Figure 1 shows a sample
assessment. This type of assessment and its related lifestyle
proﬁle can be extended to the dimensions, subdimensions,
and types.
3.3. Demonstration Study. Characteristics of the 11 adult
volunteers were as follows: mean age 57.45 years (range 43–
64), 9 male, marital status: 9 married/1 widow/1 single, 6
with university degrees, all upper-middle income. Problems
in HrH were identiﬁed in all volunteers: 8 individuals
had problems with sleep, 8 with diet, 5 with exercise, 5
with substance use, 2 with other risk habits, and 2 with
vitality/stress. Cognitive habits were good or acceptable in4 The Scientiﬁc World Journal
Table 3: Classiﬁcation system of health-related behaviors (7 domains, 3 subdomains, 43 dimensions, and 141 subdimensions).
h. Domain: health descriptors
Dimensions (5) Subdimensions (14)
h.1. Sociodemographics h.1.1. Personal information
h.1.2. Information about partner
h.1.3. Work
h.1.4. Ethnicity and culture
h.2. Family history h.2.1. Ancestors and siblings
H.2.1.1. Longevity
H.2.1.2. Medical history
h.2.2. Descendants
H.2.2.1. Longevity
H.2.2.2. Medical history
h.3. Developmental history h.3.1. Infancy
h.3.2. Childhood
H.3.2.1. Generic
H.3.2.2. Laterality
h.4. Past medical history h.4.1. Diseases/health conditions
H.4.1.1. Generic
H.4.1.2. Related symptoms
h.4.2. Surgical history
h.4.3. History of trauma or injury
h.5. Medical treatments h.5.1. Medications
H.5.1.1. Generic
H.5.1.2. Immunization history
H.5.1.3. Hormonal therapy
h.5.2. Alternative therapies
h.5.3. Other medical care within past year
c. Domain: cognition
Dimensions (7) Subdimensions (19)
c.1. Cognitive reserve (CR) c.1.1. Education level
c.1.2. Current intellectual activity
c.1.3. Current rating
C.1.3.1. Global cognitive reserve (gCR)
C.1.3.2. Global cognitive performance (gCP)
C.1.3.3. Cognitive reserve adjusted for risk (CRar)
c.2. Attention c.2.1. Attention generic
c.3. Memory c.3.1. Verbal semantic memory
C.3.1.1. Unprompted
C.3.1.2. With prompts
c.3.2. Visual memory
C.3.2.1. Items correct
C.3.2.2. Errors
c.4. Learning c.4.1. Learning curve
c.4.2. Consolidation
c.4.3. Primacy
c.4.4. Recency
c.4.5. Errors made during learning
c.4.6. Improvement with repeated exposureThe Scientiﬁc World Journal 5
Table 3: Continued.
c.5. Other intellectual functions c.5.1. Visuospatial ability
c.5.2. Motor speed
c.5.3. Perception
c.5.4. Executive function
c.6. Global cognitive decline c.6.1. Global assessment
c.6.2. Spatial/temporal orientation
c.s - Stage of change c.s.1. Observed
v. Domain: vitality and stress
Dimensions (7) Subdimensions (28)
v.1. Vitality v.1.1. Happiness
v.1.2. Optimism
v.1.3. Vital state
v.1.4. Sense of purpose
v.1.5. Sense of control (mastery)
v.1.6. Responsibility
v.1.7. Sexuality
v.2. Social reserve v.2.1. Positive relationships
v.2.2. Isolation
v.2.3. Social support
v.3. Psychosomatic reserve v.3.1. Amiability
v.2.2. Self-restraint
v.3.3. Type behavioral pattern (A, B)
v.3.4. Related health conditions
v.3.4.1. Anxiety
v.3.4.2. Depression
v.3.4.3. Rumination/obsessive tendencies
v.3.4.4. Preoccupation with health
v.4. Major life events v.4.1. Number
v.4.2. Impact
v.5. Psychological resistance to stress v.5.1. Emotional stability
v.5.2. Extraversion
v.5.3. Anxiety (trait)
v.5.4. Distress
v.5.4.1. Internalized distress
v.5.4.2. Psychological distress
v.5.5. Emotional State
v.6. Basic allostatic load v.6.1. Blood pressure
v.6.2. Waist-to-hip ratio
v.6.3. HDL
v.6.4. Total cholesterol/HDL
v.6.5. Glycated hemoglobin
v.6.6. C-reactive protein
v.s - Stage of change v.s.1. Observed
s. Domain: sleep
Dimensions (5) Subdimensions (12)
s.1. Sleep habits and quality s.1.1. Sleep schedule
s.1.2. Sleep quality
s.1.3. Other sleep-related behaviors
s.1.4. Ingestions related to sleep6 The Scientiﬁc World Journal
Table 3: Continued.
s.2. Insomnia s.2.1. Generic
s.2.2. Pattern
S.2.2.1. Onset insomnia
S.2.2.2. Middle insomnia
S.2.2.3. Late insomnia
s.3. Hypersomnia s.3.1. Somnolence
s.3.2. Nonrestorative sleep
s.4. Other sleep problems
(related health conditions)
s.4.1. Sleep apnea
s.4.2. Restless legs
s.4.3. Other sleep problems
s.s - Stage of change s.s.1. Observed
de. Domain: diet and exercise
de. Subdomains (3)
(i) deg—GENERIC
(ii) Speciﬁc
(a) d—Diet
(b) e—Exercise
Dimensions deg. (3) Subdimensions deg. (8)
deg.1. Body composition (BC)
(body mass index (BMI))
deg.1.1. BMI (generic)
deg.1.2. BMIa (adjusted)
deg.1.3. BMIar (adjusted for risk)
deg.2. BC components
(fat and lean body mass)
deg.2.1. Estimated BCC (anthropometrics formulas and standardized
calculation tables)
deg.2.2. Indirect BCC (impedance testing) BC
deg.2.3. Direct BCC (DEXA)
deg.3. Metabolic type
(see Tables 3 and 4)
deg.3.1. Classiﬁcation MT: 16 types—5 recommendations levels
deg.3.2. METs
deg.3.2.1. Estimated METs (BMI + daily activity classiﬁcation).
deg.3.2.2. Indirect METs (interview-oriented food + CPA tables).
deg.3.2.3. Direct METs (nutritional calculator and ergometry).
Speciﬁc(1) d+e( 4+4= 8) d. Diet—subdimension (12) e. Exercise—subdimension (14)
Experiences d.1. Experiences of appetite and
weight change e.1. Fatigue during activity
d.1.1. Change in appetite e.1.1. Intensity
d.1.2. Change in weight e.1.2. Frequency
e.1.3. Fatigue during leisure activities
e.1.4. Degree of interference with activity
e.1.5. Duration
Habits d.2. Diet habits e.2. Activity habits
d.2.1. Schedule e.2.1. Self-reported activity level
d.2.2. Perception of diet e.2.2. Degree of sedentariness
d.2.3. Basic eating habits e.2.3. Exercise habits
d.2.4. Type of diet e.2.4. Work-related physical activity
d.2.5. Quality of dietThe Scientiﬁc World Journal 7
Table 3: Continued.
Health-related conditions—medical
factors
d.3. Health-related conditions
(medical dietary factors)
e.3. Health-related conditions (medical activity
factors)
d.3.1. Digestive problems e.3.1. Musculoskeletal
d.3.2. Food intolerance e.3.2. Cardiovascular
d.3.3. Dental problems e.3.3. Respiratory
de.s. Stage of change: habits d.s. Stage of change—diet e.s. Stage of change—exercise
d.s.1. Observed e.s.1. Observed
d.s.2. Subjective e.s.2. Subjective
u. Domain: substance use
Dimensions (6) Subdimensions (30)
u.1. Medications u.1.1. Type
u.1.2. Initiation
u.1.3. Intensity of consumption
u.1.4. Level of abuse
u.1.5. Psychosocial and medical problems
u.2. Caﬀeine u.2.1. Type
u.2.2. Initiation
u.2.3. Intensity of consumption
u.2.4. Level of abuse
u.2.5. Psychosocial and medical problems
u.3. Nicotine u.3.1. Type
u.3.2. Initiation
u.3.3. Intensity of consumption
u.3.4. Level of abuse
u.3.5. Psychosocial and medical problems
u.4. Alcohol u.4.1. Type
u.4.2. Initiation
u.4.3. Intensity of consumption
u.4.4. Level of abuse
u.4.5. Psychosocial and medical problems
u.5. Illicit Drugs u.5.1. Type
u.5.2. Initiation
u.5.3. Intensity of consumption
u.5.4. Level of abuse
u.5.5. Psychosocial and medical problems
u.s. Stage Of Change u.s.1. Medications
u.s.1.1. Observed
u.s.1.2. Subjective
u.s.2. Caﬀeine
u.s.2.1. Observed
u.s.2.2. Subjective
u.s.3. Nicotine
u.s.3.1. Observed
u.s.3.2. Subjective
u.s.4. Alcohol
u.s.4.1. Observed
u.s.4.2. Subjective
u.s.5. Illicit drugs
u.s.5.2. Observed
u.s.5.1. Subjective8 The Scientiﬁc World Journal
Table 3: Continued.
r. Domain: other health risk habits
Dimensions (2) Subdimensions (4)
r.1. Nonadherence to treatment r.1.1. Generic
r.1.s Stage of change
r.1.s.1. Observed
r.1.s.2. Subjective
r.2. Other risk behaviors r.2.1. Type
r.2.2.1. Risky sexual behavior
r.2.2.2. Dangerous sports
r.2.2.3. Gambling
r.2.2.4. Dangerous driving
r.2.2.5. Other risk behaviors (e.g., sun exposure)
r.2.s Stage of change
r.2.s.1. Observed
r.2.s.2. Subjective
(1)Speciﬁc subdimensions of diet/exercise are listed one level down from where they are in other domains.
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Figure 1: Sample lifestyle proﬁle based on eVITAL toolkit.
Prochaska stages: precontemplation (P), contemplation (C), prepa-
ration (PP), action (A), maintenance (M), termination (T).
all individuals. 10 individuals fulﬁlled at least one diagnosis
from the International Classiﬁcation of Diseases (ICD-10)
[56] in spite of perceiving themselves as “healthy” (Table 2).
After completing the toolkit, 9/11 gave an overall favor-
able review and 11/11 reported favorable interactions with
the professionals administering the evaluation. While there
were no speciﬁc recommendations for changes from the
volunteers, 7/11 reported that the evaluation was quite long.
3.4. Feasibility Study. Upon reviewing the results of the
demonstration study, the working group and focus groups
revised the basic organization of the assessment package.
Then a feasibility questionnaire was sent to the 29 experts
involved in the focus groups; 15 responses were received
suggesting changes while 14 experts judged the previous
package as adequate and provided no further comments.
Comments about applicability of the survey were generally
positive. In terms of acceptability, there was some concern
about generalizability to populations with lower education
level and socioeconomic status, as well as whether patients
would be able to complete the forms without assistance.
Regarding practicality, there was concern about the time
required of the clinician, as well as the diﬃculty of managing
all of the data gathered. As the ultimate goal is to integrate
eVITAL into use in the primary care system, comments
from primary care practitioners, such as the following, were
particularlyimportant:“Thesurveyseemstooambitiousand
impractical for primary care...a tool that you cannot use
due to lack of resources (above all, time) loses its practical
validity.”
3.5. Development of the Toolkit. These comments were taken
into account in developing the electronic toolkit eVITAL.
Theopenaccesspreliminaryversionofthetoolkitisavailable
at http://www.longevidad.org/inicio.
4. Discussion
Althoughthereisanincreasinginterestinthecomprehensive
assessment of HrHs and their relationship to longevity [57],
this study presents the ﬁrst attempt at classifying HrHs to
date using the longevity model with the endpoint of years
lived without disability. The ICF indicates the relevance of
HrH and lifestyle as main components of the “personal
contextual factors,” but these factors have not been deﬁned
or coded to date [58].
The transtheoretical model of stages of change [17]w i t h
the related multibehavioral assessment [18] is the main
integrative approach to HrH. Despite the limited evidence
regarding the eﬀectiveness of stage-based interventions as a
basis for behavior change or for facilitating stage progressionThe Scientiﬁc World Journal 9
Table 4: Evaluation of items included in the eVITAL toolkit(1).
1. Domain: health descriptors
Evaluation Instruments
History—Level 0 Sociodemographic inventory
History—Level 1 Family medical history
Personal medical history
Medication, hormone use, and alternative treatments
Immunization history
History—Level 2
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 2
2. Domain: cognition
Evaluation Instruments
History—Level 0 Screening for cognitive problems
History—Level 1 Cognitive reserve (CR)
History—Level 2 (i) Cognitive risk factors
(ii) Cognitive reserve adjusted for cognitive risk (CRar)
(iii) Stage of change, objective [17]
History—Level 3 Global cognitive reserve (gCR)
Examination—Level 0
Examination—Level 1
Examination—Level 2 7-minute test [19, 20]
Examination—Level 3 (i) Luria’s test [21]
(ii) Benton’s visual recognition test [22]
(iii) Trail making test-A (TMT-A) [23]
(iv) Finger electronic tapping test (FETT) [24]
3. Domain: vitalty and stress
Evaluation Instruments
History—Level 0 Screening for emotional state
History—Level 1 (i) Optimism-LOT-R: life orientation test-revised [25]
(ii) Emotional stress—Questions 5–9, SF-36: social functioning-36 question scale [26, 27]/MHI-5.
(iii) Social isolation—STAKES [28]
(iv) Social support—Oslo [29]
(v) Anxiety/depression—HAD: hospital anxiety and depression scale [30]
History—Level 2 (i) NEO Pi-R: revised NEO personality inventory [31]
(ii) Psychological well-being [32, 33]
(iii) Sexuality quality of life: sexuality subscales [34, 35]
(iv) Stress—HAD [30, 36]
(v) Stage of change, objective [17]
History—Level 3 (i) Social readjustment rating scale [37]
(ii) Type A personality—ERCTA: escala retiro de patr´ on de conducta tipo A (scale of Type A behavior
pattern) [38]
(iii) Aggression subscale—ZKPQ: Zuckerman-Kuhlman’s personality questionnaire [39]
(iv) Obsessions—SPPI: standardized polyvalent psychiatric interview [40]
(v) Hypochondriasis—SPPI [40]
(vi) Gender-speciﬁc medical evaluation, including breast cancer risk assessment [41]10 The Scientiﬁc World Journal
Table 4: Continued.
Examination—Level 0
Examination—Level 1
Examination—Level 2 Basic allostatic load: blood pressure, waist-to-hip ratio, total/HDL cholesterol, HDL, glycated
hemoglobin, CRP
Examination—Level 3 Expanded allostatic load: add DHEA-S and urinary cortisol
4. Domain: sleep
Evaluation Instruments
History—Level 0 Screening for insomnia and hypersomnia
History—Level 1 (i) Insomnia—SPPI [40]
(ii) Somnolence—Epworth sleepiness scale [42–44]
(iii) Speciﬁc sleep-related symptoms
(iv) Sleep habits
History—Level 2 Stage of change, objective [17]
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 3 Polysomnography
5. Domain: diet and exercise
Evaluation Instruments
Instruments DIET Instruments EXERCISE
History—Level 0 Screening for change in appetite
(SSPI) Activity level
History—Level 1 Eating habits Exercise habits
Table of mealtimes Exercise readiness—Par-Q: physical activity
readiness questionnaire [45]
Appetite-SPPI [40] Fatigue-adapted SPPI [40]
Subclassiﬁcation BMI Estimated METs
Metabolic classiﬁcation (combines weight status and activity level) (16
levels)
Classiﬁcation as recommendations: 5 levels
Readiness to change—diet and
exercise—subjective
Readiness to change—diet and
exercise—objective
History—Level 2 CFCA-food frequency
questionnaire [46]
Digestive symptoms, food
intolerance, dental problems Musculoskeletal physical barriers to exercise
Readiness to change—diet and
exercise—objective
Readiness to change—diet and
exercise—objective
History—Level 3
Examination—Level 0 (i) Waist circumference
(ii) Reported body mass index (BMI) from reported weight and height
Examination—Level 1 (i) Body composition—subclassiﬁcation BMI
(ii) Waist-to-hip ratio
(iii) BMI adjusted for waist circumference [47], (BMIa)
Examination—Level 2 (i) Basic lab work: total/HDL cholesterol, HDL, glycated hemoglobin,
C-reactive protein, microalbumin, glucose, insulin
(ii) Blood pressure, heart rate.
(iii) Adjusted BMI (for adult weight gain, triglyceride/HDL, blood pressure, fasting glucose, and
presence or absence of sleep apnea and osteoarthritis (BMIar))
(iv) Body composition (triceps skin fold), estimated muscle mass (arm circumference)
(v) Insulin resistance-HOMA-IR [48]The Scientiﬁc World Journal 11
Table 4: Continued.
Examination—Level 3 3-day food record analyzed by
nutritionist
Indirect METs calculated through compendium
of physical activities—CPHA [49]
Hand strength via dynamometry
(i) Body composition via BIA or
DEXA (i) Somatometry
(ii) Nutritional calculator (ii) Ergometry
(iii) Direct METs measurement
6. Domain: substance abuse
Evaluation Instruments
History—Level 0 Screening for substance abuse
History—Level 1 Inventory: use and abuse of prescription medications, use of caﬀeine, nicotine, alcohol, and illicit
drugs
Adapted CAGE questionnaire for each substance [50, 51]
Stage of change for each substance, subjective
History—Level 2 (i) Stage of change for each substance, objective
(ii) For smokers: Fagerstr¨ om’s test of nicotine dependence [52, 53]
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 3 Nicotine—CO-oximetry
Alcohol—GGT, MCV
Drug levels in urine/blood/hair tests
7. Domain: other risk habits
Evaluation Instruments
History—Level 0
History—Level 1 (i) Medication adherence.
(ii) Inventory of risk behaviors: risky sexual behavior, dangerous sports, gambling, dangerous driving,
potentially dangerous travel, internet/technology addiction.
(iii) Readiness to change—subjective
History—Level 2 Readiness to change—objective
History—Level 3
Examination—Level 0
Examination—Level 1
Examination—Level 2
Examination—Level 3
(1)All tests are fully described at the eVITAL webpage (http://www.longevidad.org/). References can be downloaded at http://www.longevidad.org/descargas/
011 anexo bibliograﬁa ﬁnal.pdf.
BIA: bioelectrical impedance analysis; CO: carbon monoxide; CRP: C-reactive protein; DEXA: dual-energy X-ray absorptiometry; GGT: gamma-glutamyl
transpeptidase; HDL: high-density lipoprotein; HOMA: homeostatic model assessment; MCV: mean corpuscular volume; MHI: mental health index.
[59], multiple behavioral assessment provides a composite
index of overall behavior change and includes overarching
outcome measures such as quality of life, related biometrics,
and cost [60]. For example, a composite index for evaluating
changeinphysicalactivityanddietshowedthatinterventions
focused only on exercise achieved a larger amount of behav-
ior change than an intervention combining both physical
activity and nutrition [60].
The eVITAL expert panel opted for a global impression
rating of every major HrH and the graphical representation
of the resulting lifestyle (health proﬁle), instead of using
composite indexes. Similar global ratings have been shown
to be practical both in routine clinical practice [61] and in
eHealth tools [62].
Unexpectedlygiventheincomeandtheeducationlevelof
thevolunteersinourpilotsample,wefoundnumerousHrHs
in the “needs improvement” category, along with illnesses
both related and unrelated to HrH. We diagnosed one case
each of prostate cancer and Sj¨ ogren’s syndrome, as well
as a high proportion of sleep, diet, and exercise problems.12 The Scientiﬁc World Journal
This pilot may indicate the relevance of designing both
population- and primary care-based epidemiological studies
of health lifestyles which include all basic habits and related
conditions, as opposed to focusing speciﬁcally on targets
such as nutrition or exercise.
4.1. Study Strengths. This study is unique in its integrative
approach to the evaluation of HrH and the focus on the
middle-aged adult population. It begins to address the
barriers to health promotion in the primary care setting
recently identiﬁed in Spain [63] by providing an innovative
approach to the assessment of individuals. This preliminary
taxonomy ﬁlls an existing gap in the assessment of HrH. The
eVITAL toolkit is freely available online for use in clinical
and research settings, with the hope that this and other
groups will continue to gather information on its utility and
contribute to further reﬁnement.
4.2. Study Limitations. The taxonomy has received adequate
consensus,andtherelatedtoolsincludedineVITALarethose
deemed by group to be most useful in the development
of an integrated understanding of the HrH and lifestyle
of an individual in the Spanish cultural context. However,
the clinical utility of the toolkit as a whole will have to be
validated in the future. The current, computerized version of
eVITAL has not undergone the type of demonstration study
reported here for the earlier assessment package prototype;
thisremainstobeperformedpriortowidespreadintegration
into clinical practice. The greatest limitation of the toolkit
at this time is the concern raised about the feasibility of
widespread use of eVITAL, most notably in populations
with lower education level and socioeconomic status and
in the primary care system. While it is important to gather
enough information to develop a complete understanding of
apatient’shealthlifestyleproﬁle,thesystemweproposemust
befeasiblewithintheexistinghealthcaresystem.eVITALwill
continue to be adjusted to work toward this goal.
5. Conclusion
To our best knowledge this is the ﬁrst toolkit of lifestyle
and health-related habits based on a formal taxonomy
of HrH. This taxonomy may improve the assessment of
lifestyle in health sciences, enhance the development of a
classiﬁcation of HrH and personal factors in the context of
theWHOfamilyofclassiﬁcations,anddevelopthisconstruct
in new models of care such as person-centered medicine and
diagnosis [16, 64].
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